Quote | Eurofins Scientific S.E. ADR (OTCMKTS:ERRFY)
Last: | $11.99 |
---|---|
Change Percent: | 19.9% |
Open: | $11.99 |
Close: | $11.99 |
High: | $11.99 |
Low: | $11.99 |
Volume: | 164 |
Last Trade Date Time: | 05/11/2021 04:55:10 pm |
News | Eurofins Scientific S.E. ADR (OTCMKTS:ERRFY)
2023-08-05 10:40:00 ET Summary Eurofins is dealing with a revenue decrease due to the lack of COVID testing and the sale of reagents. Excluding the COVID-related revenue, the H1 2023 revenue would have increased by a high single digit percentage. The company slightly reduced i...
Summary Eurofins is a large life sciences company, but its COVID tailwinds are coming to an end. Apparently the market is surprised by this. I am not. The current share price weakness offers an excellent opportunity for investors with a 5-year investment horizon. Eurofins' 2027 ...
Message Board Posts | Eurofins Scientific S.E. ADR (OTCMKTS:ERRFY)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Eurofins Scientific S.E. ADR Company Name:
ERRFY Stock Symbol:
OTCMKTS Market:
Eurofins Viracor Diagnostics Launches Combined Test For COVID-19, Influenza, And RSV As The Flu Season Approaches The combined test offers an efficient and highly sensitive method to detect multiple respiratory pathogens including COVID-19 and Flu to inform treatment decisions ...
Eurofins Transplant Diagnostics Introduces TruGraf Liver At AASLD - The Liver Meeting Novel Biomarker-Based Assay Confirms Immune Quiescence in Liver Transplant Patients PR Newswire MANSFIELD, Mass., Nov. 13, 2020 MANSFIELD, Mass. , Nov. 13, 2020 /PRNewsw...
MURCIA, Spain , Aug. 24, 2020 /PRNewswire/ -- Eurofins Discovery is expanding its footprint to serve the growing market of outsourced drug discovery with its high-quality chemistry capabilities. Eurofins Villapharma is Eurofins Discovery's flagship center for synthetic chemistry, foc...